Cost‐effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person‐level data in a Canadian setting

Patients with early‐stage hepatocellular carcinoma (HCC) are potential candidates for curative treatments such as radiofrequency ablation (RFA), surgical resection (SR), or liver transplantation (LT), which have demonstrated a significant survival benefit. We aimed to estimate the cost‐effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Thein, Hla‐Hla, Isaranuwatchai, Wanrudee, Qiao, Yao, Wong, Kenny, Sapisochin, Gonzalo, Chan, Kelvin K. W., Yoshida, Eric M., Earle, Craig C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603843/
https://www.ncbi.nlm.nih.gov/pubmed/28791798
http://dx.doi.org/10.1002/cam4.1119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603843/
https://www.ncbi.nlm.nih.gov/pubmed/28791798
http://dx.doi.org/10.1002/cam4.1119

Ejemplares similares